Arclin Acquires Belle Chemical Company
September 27, 2023
Arclin completed the acquisition of Belle Chemical Company, a producer of methylamines and derivatives based in Belle, West Virginia, adding a plant of approximately 60 employees. The purchase expands Arclin's North American manufacturing capabilities and diversifies its product presence into adjacent end markets including water treatment, pharmaceuticals/healthcare, agriculture, oil & gas and electronics.
- Buyers
- Arclin
- Targets
- Belle Chemical Company
- Industry
- Manufacturing
- Location
- West Virginia, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Arclin Acquires The Willamette Valley Company
December 18, 2025
Manufacturing
Arclin has completed the acquisition of The Willamette Valley Company (WVCO), adding eight manufacturing and R&D facilities and roughly 500–540 employees to its global materials science platform. The deal expands Arclin's materials science capabilities across coatings, adhesives and repair systems and broadens its end-market exposure in wood products, railroad, concrete repair, transportation and infrastructure.
-
Arclin Acquires Polymer Solutions Group
October 2, 2025
Manufacturing
Arclin has completed the acquisition of Polymer Solutions Group (PSG), a manufacturer of proprietary polymer additives, dispersions and release agents serving the rubber, plastics and engineered wood markets. Arclin will operate PSG’s manufacturing facilities in Cleveland, Ohio and Albany, Georgia and an R&D facility in Macon, Georgia; the deal adds approximately 200 employees and expands Arclin’s product capabilities and end-market reach in construction, building products and transportation.
-
Arcline Investment Management Acquires Majority Interest in Akron Biotechnology
September 11, 2019
Biotechnology
Arcline Investment Management has acquired a majority interest in Akron Biotechnology LLC, a supplier of cGMP-compliant materials and services for cell and gene therapy manufacturers. Akron will remain led by founder and CEO Dr. Claudia Zylberberg, and Arcline plans to expand Akron's manufacturing capacity and pursue complementary acquisitions to build a platform in regenerative medicine.
-
Arcline Investment Management Invests in Actera Ingredients
August 12, 2019
Manufacturing
Arcline Investment Management, a growth-oriented private equity firm, made a strategic growth investment in Actera Ingredients to establish a bio-actives personal care platform. The capital will support Actera’s expansion of its actives portfolio, capabilities and team to serve personal care and beauty brand customers.
-
The Jordan Company Acquires Arclin from Lone Star Funds
August 16, 2021
Building Products
An affiliate of The Jordan Company has signed a definitive agreement to acquire Arclin, a Roswell, Georgia-based manufacturer of specialty resins and surface overlays, from funds affiliated with Lone Star Funds. Arclin CEO Brad Bolduc and the senior management team will retain a significant equity stake and continue to lead the business; the company operates 12 manufacturing facilities and has over 600 employees. Terms were not disclosed and the transaction was expected to close in Q3 2021.
-
Inhance Technologies Acquires Advance Research Chemicals
October 14, 2021
Manufacturing
Inhance Technologies, a portfolio company of Aurora Capital Partners, has completed the acquisition of Advance Research Chemicals (ARC), a specialty chemicals and materials producer with production facilities in the United States and Mexico. The add-on expands Inhance's capabilities in high-purity specialty chemicals, custom synthesis and private-label manufacturing to serve end markets including medical batteries, semiconductors, 3D printing and pharmaceuticals.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.